Financial Sector most active stocks: Bank of America Corp (NYSE:BAC), Citigroup Inc (NYSE:C), Wells Fargo (NYSE:WFC), JPMorgan Chase (NYSE:JPM), National Bank of Greece (ADR) (NYSE:NBG)

Breathing respite for Bank of America Corporation (NYSE:BAC), U.S. District Judge Max Cogburn hinted that he may turn down a lawsuit filed by the U.S Department of Justice (:DOJ) against the banking bellwether. The news was reported by Reuters . Bank of America Corp (NYSE:BAC) stock performance was -1.09% in last session and finished the…

Read More

Consumer Goods most Active: Apple Inc. (NASDAQ:AAPL), Lululemon Athletica inc. (NASDAQ:LULU), Ford Motor Company (NYSE:F), iShares MSCI Frontier 100 (NYSE:FM), The Coca-Cola Company (NYSE:KO)

Target Corp. has Apple Inc. (NASDAQ:AAPL)’s iPad Mini on sale for $199, a $100 savings, as well as the iPhone 5S on sale for $119.99, down from the original price of $199.99. You can also pick up Apple’s iPhone 5c for $29.99, down from $99.99. (All these deals require a new phone contract.) Apple Inc….

Read More

Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Questcor Pharmaceuticals(NASDAQ:QCOR), Seattle Genetics (NASDAQ:SGEN), Repligen Corporation (NASDAQ:RGEN), bluebird bio (NASDAQ:BLUE)

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) major shareholder Qvt Associates Gp Llc sold 128,649 shares of the company’s stock in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $7.66, for a total transaction of $985,451.34. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -6.32% in last session and finished the day…

Read More

Biotech Insider Buying: Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Cytori Therapeutics (NASDAQ:CYTX), Oramed Pharmaceuticals (NASDAQ:ORMP), Biota Pharmaceuticals (NASDAQ:BOTA)

Seattle Genetics, Inc (NASDAQ:SGEN) Director Felix Baker purchased 281,963 shares of Seattle Genetics stock in a transaction dated Wednesday, June 4th. The stock was purchased at an average price of $34.86 per share, for a total transaction of $9,829,230.18. Following the transaction, the director now directly owns 76,997 shares of the company’s stock, valued at…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓